NeuroLambda Therapeutics Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $5.5M

  • Investors
  • 1

NeuroLambda Therapeutics General Information

Description

The company is currently operating in stealth mode.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1 Broadway, 14th Floor
  • Cambridge, MA 02142
  • United States
+1 (929)
Primary Industry
Other Commercial Services
Other Industries
Other Consumer Durables
Other Financial Services
Other Services (B2C Non-Financial)
Corporate Office
  • 1 Broadway, 14th Floor
  • Cambridge, MA 02142
  • United States
+1 (929)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NeuroLambda Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 17-Jul-2024 $5.5M Completed Stealth
To view NeuroLambda Therapeutics’s complete valuation and funding history, request access »

NeuroLambda Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed
To view NeuroLambda Therapeutics’s complete cap table history, request access »

NeuroLambda Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Sherpa Healthcare Partners Venture Capital Minority
To view NeuroLambda Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

NeuroLambda Therapeutics FAQs

  • When was NeuroLambda Therapeutics founded?

    NeuroLambda Therapeutics was founded in 2023.

  • Where is NeuroLambda Therapeutics headquartered?

    NeuroLambda Therapeutics is headquartered in Cambridge, MA.

  • What industry is NeuroLambda Therapeutics in?

    NeuroLambda Therapeutics’s primary industry is Other Commercial Services.

  • Is NeuroLambda Therapeutics a private or public company?

    NeuroLambda Therapeutics is a Private company.

  • What is the current valuation of NeuroLambda Therapeutics?

    The current valuation of NeuroLambda Therapeutics is .

  • What is NeuroLambda Therapeutics’s current revenue?

    The current revenue for NeuroLambda Therapeutics is .

  • How much funding has NeuroLambda Therapeutics raised over time?

    NeuroLambda Therapeutics has raised $5.5M.

  • Who are NeuroLambda Therapeutics’s investors?

    Sherpa Healthcare Partners has invested in NeuroLambda Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »